Amy Cooper, MD
Gynecologic Oncology · Boise, IDNPI 1306880398
Payments from drug & device makers
Across 139 payments — averaging $358.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$47K
- Davol Inc.$1K
- Gen-probe, Inc.$340
- Myriad Genetic Laboratories, Inc.$269
- Seagen Inc.$246
- Tesaro, Inc.$229
- plus $754 from 12 others
What the payments were for
- Speaking & faculty fees$3,0006%
- Travel & lodging$3,1896%
- Food & beverage$6,71313%
- Education$36,88074%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 90 | $46,765 |
| Davol Inc. | 21 | $1,179 |
| Gen-probe, Inc. | 3 | $340 |
| Myriad Genetic Laboratories, Inc. | 3 | $269 |
| Seagen Inc. | 3 | $246 |
| Tesaro, Inc. | 4 | $229 |
| AstraZeneca | 4 | $209 |
| GSK | 1 | $112 |
| Pfizer | 1 | $101 |
| Clovis Oncology, Inc. | 1 | $99 |
| Merck | 1 | $71 |
| Mindray DS USA, Inc. | 1 | $50 |
| Hologic Sales And Service, LLC | 1 | $41 |
| Astellas Pharma US Inc | 1 | $16 |
| CSL Behring | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| AbbVie | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$44,153
- DAVINCI XI$750
- TIVDAK$321
- Aptima HPV$267
- co testing$267
- Aptima M genitalium$267
- Vaginitis$267
- ZEJULA$231
- ARISTA AH FLEXITIP$142
- PROGEL$140
- ARISTA$116
- PreciseTumor$116
- LYNPARZA$115
How this compares
Too few gynecologic oncology providers in Idahoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 15 | $1,020 |
| Clobetasol Propionate | 24 | $594 |
| Imiquimod | 18 | $435 |
| Ibuprofen | 15 | $74 |
| Oxycodone Hcl | 18 | $42 |
| Celecoxib | 20 | $34 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Boise
- Taylor TurnerBoise$34K
- Gerardo PerezBoise$17K
- Gerard ConnorBoise$571
- Brandy LarsonIdaho Falls$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.